Seminars in Pediatric Surgery
Volume 16, Issue 3 , Pages 205-213 , August 2007

Cancer and pediatric inflammatory bowel disease

  • Mark L. Kayton, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Mark L. Kayton, MD, Memorial Sloan-Kettering Cancer Center, Department of Surgery, Division of Pediatric Surgery, 1275 York Avenue, New York, NY 10021.

References 

  1. Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–1517
  2. Farrokhyar F, Swarbrick ET, Irvine EJ. A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol. 2001;36(1):2–15
  3. Barton JR, Gillon S, Ferguson A. Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three-fold rise in Crohn’s disease. Gut. 1989;30:618–622
  4. Sivarajasingham N, Adams SA, Smith MEF, et al. Perianal Hodgkin’s lymphoma complicating Crohn’s disease. Int J Colorectal Dis. 2003;18(2):174–176
  5. Hill DA, Dehner LP, Gow KW, et al. Perianal rhabdomyosarcoma presenting as a perirectal abscess: a report of 11 cases. J Pediatr Surg. 2002;37(4):576–581
  6. Oberto C, Schwarz KB, Zambidis E, et al. Malignant peritoneal mesothelioma in a pediatric patient mimicking inflammatory bowel disease. Dig Dis Sci. 2004;49(3):434–437
  7. Merino MJ, Livolsi VA. Small cell malignant tumors of childhood: clinically presenting as inflammatory bowel disease. Conn Med. 1979;43(10):621–624
  8. Maaravi Y, Wengrower D, Leibowitz G. A unique presentation of lymphoma of the colon. J Clin Gastroenterol. 1993;17(1):49–51
  9. McCullough JE, Kim CH, Banks PM. Mantle zone lymphoma of the colon simulating diffuse inflammatory bowel disease. Dig Dis Sci. 1992;37(6):934–938
  10. Kapoor G, Albrecht RJ, Craver R, et al. Diffuse large cell lymphoma presenting as inflammatory bowel disease in an adolescent with ataxia telangiectasia. Leuk Res. 1996;20(11-12):997–998
  11. Codling BW, Keighley MRB, Slaney G. Hodgkin’s disease complicating Crohn’s colitis. Surgery. 1977;82(5):625–628
  12. Vanbockrijck M, Cabooter M, Casselman J, et al. Primary Hodgkin disease of the ileum complicating Crohn disease. Cancer. 1993;72:1784–1789
  13. Vincenzi B, Finolezzi E, Fossati C, et al. Unusual presentation of Hodgkin’s disease mimicking inflammatory bowel disease. Leuk Lymphoma. 2001;42(3):521–526
  14. Nordenholtz KE, Stowe SP, Stormont JM, et al. The cause of death in inflammatory bowel disease: a comparison of death certificates and hospital charts in Rochester, New York. Am J Gastroenterol. 1995;90(6):927–932
  15. Ekbom A, Helmick CG, Zack M, et al. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterol. 1992;103:954–960
  16. Persson P-G, Bernell O, Leijonmarck C-E, et al. Survival and cause-specific mortality in inflammatory bowel disease: a population-based study. Gastroenterol. 1996;110:1339–1345
  17. Jess T, Loftus EV, Harmsen WS, et al. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut. 2006;55:1248–1254
  18. Jess T, Loftus EV, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology. 2006;130:1039–1046
  19. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001;91:854–862
  20. Tiszlavicz L, Kapin M, Várkonyi A, et al. Adenocarcinoma of the colon developing on the basis of Crohn’s disease in childhood. Eur J Pediatr. 2000;160:168–172
  21. Michener WM, Gage RP, Sauer WG, et al. The prognosis of chronic ulcerative colitis in children. N Engl J Med. 1961;265:1075–1079
  22. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–535
  23. Gillen CD, Andrews HA, Prior P, et al. Crohn’s disease and colorectal cancer. Gut. 1994;35:651–655
  24. Askling J, Dickman PW, Karlén P, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001;120:1356–1362
  25. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med. 1990;323:1228–1233
  26. Ekbom A, Helmick C, Zack M, et al. Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement. Lancet. 1990;336:357–359
  27. Gumaste V, Sachar DB, Greenstein AJ. Benign and malignant colorectal strictures in ulcerative colitis. Gut. 1992;33(7):938–941
  28. Stahl TJ, Schoetz DJ, Roberts PL, et al. Crohn’s disease and carcinoma: increasing justification for surveillance?. Dis Colon Rectum. 1992;35:850–856
  29. Heuschen UA, Hinz U, Allemeyer EH, et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology. 2001;120:841–847
  30. Broomé U, Löfberg R, Veress B, et al. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology. 1995;22(5):1404–1408
  31. Marchesa P, Lashner BA, Lavery IC, et al. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol. 1997;92(8):1285–1288
  32. Shetty K, Rybicki L, Brzezinski A, et al. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol. 1999;94(6):1643–1649
  33. Knechtle SJ, D’Alessandro AM, Harms BA, et al. Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery. 1995;118(4):615–620
  34. Loftus EV, Aguilar HI, Sandborn WJ, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology. 1998;27(3):685–690
  35. Vera A, Gunson BK, Ussatoff V, et al. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation. 2003;75(12):1983–1988
  36. Siegel CA, Sands BE. Risk factors for colorectal cancer in Crohn’s colitis: a case-control study. Inflamm Bowel Dis. 2006;12(6):491–496
  37. Choi PM, Nugent FW, Schoetz DJ, et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993;105:418–424
  38. Collins PD, Mpofu C, Watson AJ, et al. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev. 2006;2:CD000279
  39. Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut. 2002;51(suppl V):v10–v12
  40. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?. Lancet. 1994;343:71–74
  41. Itzkowitz SH. Cancer prevention in patients with inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:1133–1144
  42. Sarigol S, Wyllie R, Gramlich T, et al. Incidence of dysplasia in pelvic pouches in pediatric patients after ileal pouch-anal anastomosis for ulcerative colitis. J Pediatr Gastroenterol Nutr. 1999;28(4):429–434
  43. Remzi FH, Fazio VW, Delaney CP, et al. Dysplasia of the anal transition zone after ileal pouch-anal anastomosis. Dis Colon Rectum. 2003;46:6–13
  44. Ejderhamn J, Rafter JJ, Strandvik B. Faecal bile acid excretion in children with inflammatory bowel diseaes. Gut. 1991;32:1346–1351
  45. Tung BY, Emond MJ, Haggitt RC, et al. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med. 2001;134:89–95
  46. Pardi DS, Loftus EV, Kremers WK, et al. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology. 2003;124:889–893
  47. Sjöqvist U, Tribukait B, Öst Á, et al. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study. Anticancer Res. 2004;24:3121–3128
  48. Reinacher-Schick A, Schoeneck A, Graeven U, et al. Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells. Carcinogenesis. 2003;24(3):443–451
  49. Eaden J, Abrams K, Ekbom A, et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther. 2000;14:145–153
  50. van Staa TP, Card T, Logan RF, et al. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut. 2005;54:1573–1578
  51. Bernstein CN, Blanchard JF, Metge C, et al. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?. Am J Gastroenterol. 2003;98:2784–2788
  52. Terdiman JP, Steinbuch M, Blumenthals WA, et al. 5-Aminosalicylic acid therapy and the risk of colrectal cancer among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:1–5
  53. Freudenheim JL, Graham S, Marshall JR, et al. Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol. 1991;20(2):368–374
  54. Persson P-G, Karlén P, Bernell O, et al. Crohn’s disease and cancer: a population-based cohort study. Gastroenterol. 1994;107:1675–1679
  55. Munkhold P, Langholz E, Davidsen M, et al. Intestinal cancer risk and mortality in patients with Crohn’s disease. Gastroenterology. 1993;105:1716–1723
  56. Lashner BA. Risk factors for small bowel cancer in Crohn’s disease. Dig Dis Sci. 1992;37(8):1179–1184
  57. Henderson RG, Long PJ, Al-Nafussi AI, et al. Paget’s disease with benign osteopetrosis and Crohn’s disease. J R Soc Med. 1985;78(9):766–768
  58. Cameron EM, Raeburn A, Ford MJ. Neurofibromatosis and inflammatory bowel disease. Scott Med J. 1989;34(4):500–501
  59. Pfeffel F, Stiglbauer W, Depisch D, et al. Coincidence of Crohn’s disease and a high-risk gastrointestinal stromal tumor of the terminal ileum. Digestion. 1999;60:363–366
  60. Mijandrušic Sinèic B, Kovac D, Jašic M, et al. Crohn’s disease and a gastrointestinal stromal tumor in an 81-year-old man: a rare coincidence. Zentralbl Chir. 2005;130:597–599
  61. Laukhuf F, Tischer KH, Strobel K, et al. Crohn’s disease and stromal sarcoma of the small bowel: a rare coincidence. Z Gastroenterol. 2002;40(3):193–196
  62. Papadopoulos N, Goritsas C, Rontogianni D, et al. Coexistence of inflammatory bowel disease and gastrointestinal stromal tumor: a case report. Int J Intern Med. 2003;4:7–9
  63. Listinsky CM, Halpern NB, Workman RB, et al. Ultrastructural and immunocytochemical features of a case of neuroendocrine carcinoma developing in a prior ileostomy site. Ultrastruct Pathol. 1994;18(5):503–509
  64. Le Marc’hadour F, Bost F, Peoc’h M, et al. Carcinoid tumour complicating inflammatory bowel disease. Pathol Res Pract. 1994;190:1185–1192
  65. Greenstein AJ, Balasubramanian S, Harpaz N, et al. Carcinoid tumor and inflammatory bowel disease: a study of eleven cases and review of the literature. Am J Gastroenterol. 1997;92(4):682–685
  66. Sigel JE, Goldblum JR. Neuroendocrine neoplasms arising in inflammatory bowel disease: a report of 14 cases. Mod Pathol. 1998;11(6):537–542
  67. Israel KJ, Nissenblatt MJ. Association of inflammatory bowel disease (IBD) with indolent soft-tissue sarcomas: report of two cases and review of literature. J Surg Oncol. 1986;32(2):125–130
  68. DiGiacomo JC, Lazenby AJ, Salloum LJ. Mesenteric fibromatosis associated with Crohn’s disease. Am J Gastroenterol. 1994;89(7):1103–1105
  69. Slater G, Greenstein AJ. Mesenteric fibromatosis in Crohn’s disease. J Clin Gastroenterol. 1996;22(2):147–149
  70. Greenstein AJ, Sachar DB, Shafir M, et al. Malignant melanoma in inflammatory bowel disease. Am J Gastroenterol. 1992;87(3):317–320
  71. Slater G, Greenstein A, Aufses AH. Anal carcinoma in patients with Crohn’s disease. Ann Surg. 1984;199(3):348–350
  72. Kulaylat MN, Doerr R, Butler B, et al. Squamous cell carcinoma complicating idiopathic inflammatory bowel disease. J Surg Oncol. 1995;59(1):48–55
  73. Frisch M, Johansen C. Anal carcinoma in inflammatory bowel disease. Br J Cancer. 2000;83(1):89–90
  74. Greenstein AJ, Gennuso R, Sachar DB, et al. Extraintestinal cancers in inflammatory bowel disease. Cancer. 1985;56:2914–2921
  75. Ekbom A, Helmick C, Zack M, et al. Extracolonic malignancies in inflammatory bowel disease. Cancer. 1991;67:2015–2019
  76. Thompson GB, Pemberton JH, Morris S, et al. Kaposi’s sarcoma of the colon in a young HIV-negative man with chronic ulcerative colitis. Dis Colon Rectum. 1989;32(1):73–76
  77. Puy-Montbrun T, Pigot F, Vuong PN, et al. Kaposi’s sarcoma of the colon in a young HIV-negative woman with Crohn’s disease. Dig Dis Sci. 1991;36(4):528–531
  78. Koop HO, Holodniy M, List AF. Fulminant Kaposi’s sarcoma complicating long-term corticosteroid therapy. Am J Med. 1987;83(4):787–789
  79. Tedesco M, Benevolo M, Frezza F, et al. Colorectal Kaposi’s sarcoma in an HIV-negative male in association with ulcerative rectocolitis: a case report. Anticanc Res. 1999;19:3045–3048
  80. Cohen RL, Tepper RE, Urmacher C, et al. Kaposi’s sarcoma and cytomegaloviral ileocolitis complicating long-standing Crohn’s disease in an HIV-negative patient. Am J Gastroenterol. 2001;96:3028–3031
  81. Bursics A, Morvay K, Ábrahám K, et al. HHV-8 positive, HIV negative disseminated Kaposi’s sarcoma complicating steroid dependent ulcerative colitis: a successfully treated case. Gut. 2005;54(7):1049–1050
  82. Meltzer SJ, Rotterdam HZ, Korelitz BI. Kaposi’s sarcoma occurring in association with ulcerative colitis. Am J Gastroenterol. 1987;82(4):378–381
  83. Adlersberg R. Kaposi’s sarcoma complicating ulcerative colitis: report of a case. Am J Clin Pathol. 1970;54(1):143–146
  84. Gordon HW, Rywlin AM. Kaposi’s sarcoma of the large intestine associated with ulcerative colitis. Gastroenterology. 1966;50(2):248–253
  85. Mackey AC, Green L, Liang L-C, et al. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2007;44:265–267
  86. Ljung T, Karlén P, Schmidt D, et al. Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County. Gut. 2004;53:849–853
  87. Sandborn WJ, Loftus EV. Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease. Gut. 2004;53:780–782
  88. Lewis JD, Bilker WB, Brensinger C, et al. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology. 2001;121:1080–1087
  89. Loftus EV, Tremaine WJ, Habermann TM, et al. Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol. 2000;95:2308–2312
  90. Askling J, Brandt L, Lapidus A, et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut. 2005;54:617–622
  91. Kandiel A, Fraser AG, Korelitz BI, et al. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut. 2005;54:1121–1125
  92. Sonwalkar SA, James RM, Ahmad T, et al. Fulminant Crohn’s colitis after allogeneic stem cell transplantation. Gut. 2003;52:1518–1521
  93. Sklar C, Boulad F, Small T, et al. Endocrine complications of pediatric stem cell transplantation. Front Biosci. 2001;6:g17–g22
  94. Ditschkowski M, Einsele H, Schwerdtfeger R, et al. Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation. Transplantation. 2003;75(10):1745–1747
  95. Oyama Y, Craig RM, Traynor AE, et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn’s disease. Gastroenterology. 2005;128:552–563
  96. Itzkowitz SH, Present DH. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11(3):314–321

PII: S1055-8586(07)00029-7

doi: 10.1053/j.sempedsurg.2007.04.010

Seminars in Pediatric Surgery
Volume 16, Issue 3 , Pages 205-213 , August 2007

Article Tools